Human T lymphocyte (T cell) (T cell)

Human T lymphocytes, commonly known as T cells, are a major type of white blood cell and a cornerstone of the adaptive immune system (StatPearls: NBK554420). They originate from hematopoietic stem cells in the bone marrow and undergo maturation in the thymus, where they develop a unique T-cell receptor (TCR) capable of recognizing specific antigens presented by major histocompatibility complex (MHC) molecules (NIH: Immune System Overview). T cells are categorized into functional subsets, primarily helper T cells (CD4+), which coordinate immune responses, and cytotoxic T cells (CD8+), which directly kill infected or cancerous cells (Wikipedia: T cell). In therapeutic contexts, T cells are not a single molecular target but a cellular population targeted by various drugs; for instance, immunosuppressants like cyclosporine inhibit their activation to prevent transplant rejection, while checkpoint inhibitors like pembrolizumab reinvigorate exhausted T cells to treat cancer (PubChem: Cyclosporine; FDA: Keytruda). Dysregulation of T-cell activity is central to the pathogenesis of autoimmune diseases, chronic inflammation, and immunodeficiencies such as HIV/AIDS (NCBI: Immune System and Disease).

Other names

T-cellThymus-derived lymphocyteCD3+ lymphocyteT lymphocyte

Therapeutic strategies involving T cells include calcineurin inhibition to block IL-2 production and T-cell proliferation, monoclonal antibody-mediated depletion of CD3+ cells, and immune checkpoint blockade to prevent T-cell exhaustion and enhance anti-tumor activity (StatPearls: NBK554420; FDA: Keytruda).